4-Fluorobenzamide - CAS 824-75-9
Catalog: |
BB036840 |
Product Name: |
4-Fluorobenzamide |
CAS: |
824-75-9 |
Synonyms: |
4-fluorobenzamide; 4-fluorobenzamide |
IUPAC Name: | 4-fluorobenzamide |
Description: | 4-Fluorobenzamide (CAS# 824-75-9) is a useful research chemical compound. |
Molecular Weight: | 139.13 |
Molecular Formula: | C7H6FNO |
Canonical SMILES: | C1=CC(=CC=C1C(=O)N)F |
InChI: | InChI=1S/C7H6FNO/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,(H2,9,10) |
InChI Key: | VNDHYTGVCGVETQ-UHFFFAOYSA-N |
Boiling Point: | 287 °C |
Density: | 1.43 g/cm3 |
MDL: | MFCD00007992 |
LogP: | 1.62490 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113426482-A | Application method of sodium triethylborohydride, organic amine compound and preparation method thereof | 20210727 |
CN-112961079-A | Method for dehydrating primary amide into nitriles by cobalt catalysis | 20210304 |
CN-112250675-A | Tyrosine kinase inhibitor containing amide structure and preparation method thereof | 20201119 |
CN-112299938-A | Method for preparing amine compound by reducing amide compound | 20201112 |
CN-111875515-A | Method for generating amide by catalyzing primary amine with metal complex | 20200904 |
PMID | Publication Date | Title | Journal |
22278093 | 20120501 | Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology |
22479518 | 20120101 | Molecular evolution of the neuropeptide S receptor | PloS one |
22574506 | 20120101 | Metabolic stability of new anticonvulsants in body fluids and organ homogenates | Acta poloniae pharmaceutica |
21707994 | 20110627 | The asthma candidate gene NPSR1 mediates isoform specific downstream signalling | BMC pulmonary medicine |
21466221 | 20110428 | Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68) | Journal of medicinal chemistry |
Complexity: | 130 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 139.043341977 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 139.043341977 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 43.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS